(Q45067830)

English

Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication

scientific article published in October 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

1 reference

based on heuristic

inferred from title

author name string

Edgar Kockelmann

1

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Christian E Elger

2

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Christoph Helmstaedter

3

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

publication date

1 October 2004

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Epilepsy Behavior

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

716-721

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Novel mechanisms of action of three antiepileptic drugs, vigabatrin, tiagabine, and topiramate

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.017

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.017

7 January 2021

Serum concentrations of topiramate in patients with epilepsy: influence of dose, age, and comedication

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.017

7 January 2021

Postmarketing experience with topiramate and cognition

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.017

7 January 2021

Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.017

7 January 2021

Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.017

7 January 2021

Safety of topiramate: adverse events and relationships to dosing

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.017

7 January 2021

Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.017

7 January 2021

A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.017

7 January 2021

Effects of topiramate on cognitive function

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.017

7 January 2021

Cognitive impairments due to add-on therapy with topiramate

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.017

7 January 2021

Low-dose topiramate in adults with treatment-resistant partial-onset seizures

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.017

7 January 2021

Topiramate in the preventive treatment of episodic migraine: a combined analysis from pilot, double-blind, placebo-controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.017

7 January 2021

Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.017

7 January 2021

Language Disturbances as Side Effects of Topiramate and Zonisamide Therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.017

7 January 2021

The effects of adjunctive topiramate on cognitive function in patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.017

7 January 2021

Effect of topiramate on attention

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.017

7 January 2021

Cognitive and behavioral effects of antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.017

7 January 2021

Neuropsychological effects of epilepsy and antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.017

7 January 2021

Significant improvement in frontal lobe associated neuropsychological functions after withdrawal of topiramate in epilepsy patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.017

7 January 2021

Identifiers

10.1016/J.YEBEH.2004.06.017

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45067830&oldid=2064488764"